Skip to main content

MoneyWorks4Me

Lupin informs about earnings call

28 Jan 2023 Evaluate

Pursuant to Regulation 30(2) read with Schedule III Part A Para A(15) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, Lupin has informed that Earnings Call for Quarter - III, FY 2023 (invite copy enclosed) is scheduled on Friday, February 10, 2023, at 16.00 hrs (IST). Transcripts of the said Call will be filed electronically with the Exchange pursuant to the aforesaid Regulations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..